Top compounds associated with response to ENC1


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.011 0.8
mRNA GW843682X GDSC1000 pan-cancer AAC -0.019 0.8
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.012 0.8
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA temsirolimus FIMM pan-cancer AAC 0.057 0.8
mRNA YM-155 GDSC1000 pan-cancer AAC 0.011 0.8
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.012 0.8
mRNA CAY10594 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.01 0.8
Download CSV